NCT06396065 2026-03-24Phase III Study of AK112 for NSCLC PatientsSummit TherapeuticsPhase 3 Active not recruiting420 enrolled
NCT05184712 2026-03-04Phase 3 Clinical Study of AK112 for NSCLC PatientsAkesoPhase 3 Active not recruiting322 enrolled